Ivonescimab
Colorectal Liver Metastases
Cancer Institute and Hospital, Chinese Academy of Medical Sciencesmonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
3 Active assets in the Colorectal Liver Metastases cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM Assistance Publique - Hôpitaux de Paris | Phase 3 | BB |
Irinotecan Assistance Publique - Hôpitaux de Paris | Phase 3 | B |
Calcium folinate pentahydrate Assistance Publique - Hôpitaux de Paris | Phase 3 | B |
Eloxatin David Bartlett | Phase 1 | CC |
Same molecule, other indications
Ivonescimab is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →